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SURGICAL OUTCOMES OF RECURRENT MACULAR HOLE 
ARYA SHARIFZADEH 
ABSTRACT 
 Idiopathic macular hole is a disease of the eye with unknown cause, but a 
pathology that, over the course of several decades of investigation by clinicians and 
researchers alike, has become readily treatable with surgical intervention at a very high 
rate of successful repair. The current study presents a retrospective case series exploring 
surgical outcomes for treatment of recurrent macular holes. The study additionally 
provides a window into the past, present, and future of macular holes across all clinical 
considerations, and importantly performs a supplementary statistical meta analysis of 
reoperation success rates in the relevant field of published data– the first of its kind. The 
introductory background of the present study establishes a natural history of idiopathic 
macular holes in clinical discovery, classification, and management. The study’s case 
series data specifically focuses on the phenomenon of macular hole recurrence, offering 
surgical outcome measures of patients undergoing primary and secondary repair 
operations in a single-center, single-surgeon design. The findings of the retrospective 
series support the hypothesis that macular hole reoperation does achieve successful 
anatomical closure in a majority of cases. A meta analysis performed on the current field 
of published clinical research pertaining to recurrent macular holes established 
cumulative success rates across a variety of surgical conditions. The present study’s 
findings were then compared to the corresponding measures across the landscape of 
recurrent macular hole literature, to help inform a niche of clinical research that continues 
	  	   vii 
to be an area of investigation and discovery. In presenting a cohesive, synthesized 
narrative of recurrent macular holes, the study provides a foundation wherein ongoing 
collaborative efforts in the field can continue to build upon a blueprint currently set in 
place, and work towards finding a cause behind an otherwise idiopathic disease.  
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INTRODUCTION 
Anatomic considerations 
 The eye is among the most complex and intricate organs of the human body, 
responsible for the functionality of mankind’s ever-precious sense of sight. Three distinct 
layers inside the human eye are traditionally delineated anatomically. The outermost 
region, part of which acts to refract and transmit light, is made up of the cornea and 
sclera. The eye’s pigmented middle layer, which serves to provide nutrients, regulate 
light passage, and control overall power and shape of the crystalline lens, consists of the 
choroid, iris, and ciliary body. Lastly, an inner light-capturing and neural processing 
region is defined as the neurosensory retina. There exist three additional transparent 
structures surrounded by these aforementioned ocular layers, and they are defined as the 
aqueous, vitreous, and lens of the eye respectively (1).  
 Figure 1: Structure of the eye and ocular barriers. Figure taken from Willoughby  
 et al., 2008 (1). 
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 Retinal tissue, lining the eye’s innermost surface around the vitreous cavity, can 
further be divided into a neural retina and retinal pigment epithelium. The latter of these 
layers is formed by a cuboidal epithelial monolayer, and acts to maintain the function of 
photoreceptors, overall retinal adhesion, as well as vitamin A storage and metabolism. 
Within the neural retina, six major classes of neurons (photoreceptors, bipolar cells, 
horizontal cells, amacrine cells, ganglion cells, Müllerian glia) are arranged in parallel 
layers and serve to both capture and process light signals (1).  
  Figure 2:  Cells and layers of the retina. Figure taken from Willoughby et al.,  
 2008 (1).  
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 The macula is a small (5 mm diameter) portion of the retina in which roughly half 
of the human eye’s cones (photoreceptors responsible for color vision) are found to be 
concentrated (1). At the macula’s center there lies an excavation (1500 µm diameter) 
called the fovea. While this particular area of the retina is responsible for sharp central 
vision and acuity, it is importantly defined clinically by annular light reflexes off of an 
internal limiting membrane (ILM) of Müller cells composed of type IV collagen (1, 2). 
The vitreous cortex, consisting of densely packed type II collagen fibrils, is attached to 
the retina by varying location-dependent degrees such that overall vitreoretinal adherence 
is strongest at the fovea, the site where the retina’s ILM is at its thinnest (2).  
Figure 3: The funds of the eye. Macula, fovea, and the optic disc. Figure taken 
from Willoughby et al., 2008 (1). 
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Historical Background  
 The ocular condition now identified clinically as macular hole (MH) presented 
ophthalmologists with challenges and bewilderment for decades before the medical 
community collectively reached a formal classification. Throughout the 1970s and 1980s, 
a number of retrospective clinical studies were carried out with aims of better interpreting 
the signs and symptoms that accompanied macular hole progression (refs for these 
studies). Early investigations pointed to central foveal depressions, the result of macular 
thinning, as one of several potential precursors to hole formation (3). Investigators at the 
time additionally hypothesized on possible links between macular hole formation and 
ocular pathologies including retinal pigment epithelium disease, systemic vascular 
disorders, and macular cyst degeneration, among others (2, 3). As very few patients ever 
observed palpable symptom onset during the condition’s earliest stages, opportunities to 
clinically observe the initial development and evolution of a macular hole were extremely 
limited.  
 The first definitive breakthrough in the clinical exploration of macular holes came 
by way of two 1988 American Medical Association publications by Dr. Donald M Gass, 
who has since been widely recognized as the “Father of Macular Disease”, and his 
colleague Dr. Robert N. Johnson (2, 4). Gass presented evidence for a condition he gave 
the denomination idiopathic macular hole, a pathological result of focal shrinkage of the 
vitreous cortex in the area of the fovea (4).  Rather than solely retrospectively reviewing 
his pool of 250 patients with confirmed fully developed idiopathic macular holes, Gass 
critically identified photographs of 15 patients from a twenty-year period (between 1966 
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and 1986) whom he believed were representative of early stage “prehole” cases (4). As a 
result of observing patients across a spectrum of macular hole evolution, Gass was able to 
provide clinical illustrations of early idiopathic macular hole developmental 
characteristics, a thorough hypothesizing of disease pathogenesis, and clinical opinion 
regarding the potential feasibility for surgical intervention. 
 Figure 4: Development of idiopathic macular hole. A single patient across  
 there different stages of pathogenesis (Left: December 1968, Center: January  
 1969, Right: February 1969). Taken from Gass 1988 (4). 
  
 Preliminarily, Gass classified a detectable state of impending hole formation, 
which he termed more broadly as “stage 1 lesion”, to be the first clinical step in 
pathogenesis. This initial stage was found markable by the development of a yellow spot 
or ring (left panel of Figure 4) in the center of the fovea, loss of foveal depression, and 
absence of any separation by the vitreous from the foveal retina (4). Gass also observed 
the potential for some patients in this initial stage to undergo sudden vitreous separation 
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without hole formation, although the vast majority of cases did present a progression of 
disease pathogenesis without any spontaneous amelioration of conditions. 
 In parallel with these foundational clinical findings, Gass and Johnson later 
completed a secondary review of 158 eyes in which idiopathic macular holes were either 
evolving or completely formed (5). The observations that followed lent credence to the 
hypothesis that idiopathic macular holes develop as the result of perifoveal vitreous 
cortex contraction. Histopathologic studies following the publication of the Gass 
hypothesis of macular hole formation went on to confirm tangential vitreous cortex 
traction as the principal mechanism underlying disease pathogenesis (2).  
 The advent of Optical coherent tomography (OCT) as a diagnostic imaging 
technique in ophthalmology functioned to further add detail to macular hole 
classification. The high-resolution, 2-dimensional cross sectional images of the retina 
have become paramount in both making a diagnosis and assigning corresponding staging 
to macular holes (2). Gaudric et al (6) presented an invaluable study using OCT-
generated data to conclusively illustrate a schematic of hole formation wherein posterior 
hyaloid detachment, beginning around the macula, functions along with the action of 
anteroposterior forces (due to the hyaloid remaining adherent to the foveolar center) to 
result in an intraretinal split. This initial pathological development progresses and evolves 
into the creation of a cystic space, which consequently generates a disruption of the outer 
retinal layer and an opening of the foveal floor (6). This sequence of events critically 
provided a definitive characterization of each step in the clinical progression from 
vitreofoveal traction of full-thickness macular hole (FTMH) formation. 
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 Figure 5: Representation of macular hole formation. Taken from Gaudric et al.,  
 1999 (6).  
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 Figure 6: Optical Coherence topography of macular hole. Full-thickness with  
 separation of the posterior vitreous from the fovea.  Taken from Huang et al.,  
 2011 (7).  
Clinical Classification: Stages of Idiopathic Macular Hole   
 As initially described by Gass, macular hole formation typically evolves 
throughout a period of weeks to months over the course of four distinct stages (4). The 
original Gass definitions of each respective stage have undergone some degree of 
revision, but remain largely consistent with their earliest versions. The stages of 
formation and descriptive characteristics that follow are informed by the American 
Academy of Ophthalmology’s Preferred Practice Pattern Guidelines, a current standard in 
clinical diagnosis of idiopathic macular holes (8).  
 Stage 1 (Impending Macular Holes):  
 Important in clinical classification of macular hole stages is the lack of a retinal 
defect in stages defined as 1-A and 1-B. For this reason, both subdivisions of stage 1 
macular holes are more generally referred to as “impending” (8).  In stage 1-A, there is a 
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characteristic loss of foveal depression and the appearance of a foveal spot sized 100 - 
200 µm in diameter. This primary characteristic is critical in differentiating 1-A from 1-B 
impending holes, as stage 1-B is defined by the formation of a yellow ring 200 - 250 µm 
in diameter. In stage 1-A impending macular hole, there is an observed localized shallow 
detachment of the perifoveal vitreous cortex while still remaining adherent to the foveola, 
and, in some cases, a horizontal splitting at the fovea (a pseudocyst) that corresponds to 
the aforementioned yellow spot. By contrast, in stage 1-B impending macular hole there 
is a posterior extension of the pseudocyst that occurs with disruption of the outer retinal 
layer, while the retinal roof remains intact by the retina’s persisting adherence to the 
posterior hyaloid (8). Both 1-A and 1-B feature visual acuity ranges from 20/25 to 20/80, 
and neither stage is accompanied by a recommendation for surgical intervention (8).  
 Stage 2: Stage 2 macular holes are classified as small full-thickness (<400 µm 
diameter) retinal defects. As is the case in stage 1-A and 1-B, overall acuity remains in 
the 20/25 to 20/80 ranges, however distorting visual symptoms such as metamorphosia 
(straight lines appearing as wavy) are often observed. It should additionally be noted that 
in neither stage 1 nor stage 2 macular holes are epiretinal membranes commonly present.  
 Stage 3: Stage 3 macular holes are defined as clinically full-thickness macular 
holes equal to or larger than 400 µm in diameter. It is in this stage where the posterior 
hyaloid is largely separated from the macula, with possible persisting attachment at the 
optic disc or peripheral regions. Additionally, stage 3 holes feature an operculum (flap) 
present on the posterior hyaloid over the hole, which is detectable clinically by means of 
OCT imaging. In some cases, stage 3 holes can also feature a cuff of subretinal fluid with 
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intraretinal edema, or even the occasional appearance of drusen-like yellowish deposits in 
the base of the hole. Often times in patients with long-standing cases of stage 3 macular 
hole, there is a rim of hyper- or hypo-pigmentation of the RPE at the junction between 
detached and normal-appearing retina. Visual acuity ranges tend to fall between 20/100 
and 20/400, and epiretinal membranes may be present at this stage (8).  
 Stage 4: Stage 4 full-thickness holes are larger in size than their stage 3 
predecessors, and are characterized by a complete posterior vitreous detachment (PVD) 
and the presence of a Weiss ring, clinically signified by a condensed, thickened posterior 
surface of the vitreous that pulls away from the optic disc. (4, 8). Cuffs of subretinal fluid 
are usually present at this stage, and epiretinal membranes are also found to occur more 
frequently. Visual acuity tends to decrease more profoundly into the 20/100 to 20/400 
range. 
 As it stands today, clinical data would suggest that roughly 50% of stage 1-A or 
1-B impending holes progress to a full-thickness macular hole. When disease progression 
continues beyond stage 2, patients experience significant vision loss and debilitation 
without treatment. Additionally, the gradual increasing of macular hole enlargement can 
often lead to the development of epiretinal membranes, a pathologic puckering of the 
macula that often creates further visual impairments and poorer overall prognoses (2, 4, 
5, 8). 
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 Figure 7: Idiopathic macular hole formation in different stages. Taken from Lam  
 et al., 1999 (2).  
 Idiopathic macular holes can be associated to some degree with changes in the 
human eye as a result of aging. Natural, age-related changes to the degree of vitreoretinal 
adherence in the eye could potentially result in the onset of macular holes in even the 
healthiest of patients. Epidemiological findings of one case-control study found that over 
50% of idiopathic macular holes were found in individuals aged 65 to 74 years old, with 
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only 3% prevalence in those under the age of 55 (8). Incidence rates of idiopathic 
macular holes are significantly higher in women than men (8).  
 Patients who present with a macular hole in the clinic typically experience blurred 
central vision, in addition to the aforementioned symptoms of metamorphosia. In 
asymptomatic patients, holes are often noticed during routine eye examinations — 
informed both by physicians’ observations during ophthalmoscopy and OCT image 
analysis. In making a differential diagnosis, clinicians are sure to distinguish macular 
hole from other forms of ocular disease that may mimic its symptoms, ranging from 
lamellar holes (partial thickness macular holes whose symptoms do not typically progress 
or require surgical intervention), to foveal cysts and epiretinal membranes. (2). The use of 
Watzke-Allen slit beam testing is a traditional method of clinical examination that may 
be helpful in confirming macular hole diagnoses made by OCT. Both fluorescein 
angiography and scanning laser ophthalmoscopy are additional auxiliary eye center tests 
that can prove useful in making a differential diagnosis in the most difficult of 
presentations (2).  
Surgical Interventions and Management  
 As is the case with many pathologies of the eye, early detection and diagnosis is 
associated with better success in management and intervention. In some patients 
presenting with stage 1-A or early 1-B lesions there is the chance for spontaneous 
resolution of symptoms in the eye following vitreofoveal separation without treatment, 
wherein the appearance of the fovea consequently returns to normal or appears as a 
reddish spot (8). As only about 50% of impending macular holes progress to full-
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thickness macular holes, in those cases with spontaneous vitreous detachment there is 
typically a rapid improvement and amelioration of visual symptoms. For this reason, the 
recommended management for stage 1-A and 1-B macular hole is close observation, with 
regular follow-ups every 2 to 4 months in the absence of new symptom onset.  As 
macular holes progress to stage 2 and beyond, their enlargement is accompanied by 
progressive vision loss and increased chances of epiretinal membrane development. 
However, some case series have interestingly observed spontaneous resolution with hole 
closure and foveal contour restoration to occur in a very small minority, 2-3%, of full-
thickness macular holes (8). In order to halt further disease progression and loss of 
central visual function, macular holes categorized or stage 2 or later are recommended to 
undergo vitreous surgery (2, 4, 5, 8). 
Surgical Technique 
 The current clinical standard of surgery in treatment of full-thickness macular 
holes is that of pars plana vitrectomy (PPV) operation. The principal anatomic goal 
underlying a PPV procedure is to separate the posterior cortical hyaloid from the retinal 
surface with a careful surgical technique. Upon successful completion of this primary 
objective, procedures conclude with the creation of a retinal tamponade to achieve 
anatomic macular hole closure (2,8).  Several different agents can be employed to carry 
out this intraocular liquid exchange, with options for agents ranging from the use of air 
alone to sulfur hexafluoride (SF6), perfluoropropane (C3F8), or silicone oil. 
 The clinical utility of pars plana vitrectomy in treatment of full-thickness macular 
holes was first demonstrated by Dr.’s Neil E. Kelly and Robert T. Wendel in a landmark 
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1991 publication (9). Their pragmatic clinical approach offered major contributions to 
clinical management of a condition previously considered untreatable. Operating on a 
series of 52 patients with full-thickness (stage 3 or 4) macular holes, Kelly and Wendel 
carried out a procedure consisting of PPV, removal of adherent cortical vitreous, 
stripping of epiretinal membranes, and a total SF6 fluid-gas exchange. This pilot study 
established detailed protocol on the various instruments used in surgery, as well as 
preoperative and postoperative observations for each patient. Importantly, their series 
also offered specific techniques for aspiration during vitreous detachment, and a method 
for usage of silicone tip extrusion needles in identification and removal of adherent 
posterior cortical hyaloid (9).  
 Figure 8: Original surgical technique. Sweeping silicone-tipped   
 extrusion needle over the retinal surface to identify adherent cortical  
 vitreous (the so-called “fish-strike” sign) Taken from Kelly and Wendel, 1991 (9).  
 Kelly and Wendel were able to successfully perform their procedure and reattach 
detached macula in 30 (58%) of the eyes they operated on (9), and, of particular value to 
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clinicians, laid a cornerstone upon which all  future surgical intervention mechanisms in 
the treatment of macular holes could be built. 
 Since the preliminary introduction of the Kelly and Wendel protocols in macular 
hole surgery, both the modification of medical instruments and gradual refinement of 
technique for tissue removal have rendered the success rate of postoperative hole 
flattening to be now nearly 90% efficient. The following considerations are currently part 
of standard preoperative treatment plans for clinicians and their patients in surgical 
management of idiopathic macular holes. 
Considerations of Intraocular Tamponade:  
 While the medical community has yet to reach a definitive consensus on the 
single best choice of tamponade agent in vitreous surgery, there are many factors that 
impact physicians’ selections when carrying out macular hole treatment procedures. 
Among the gasses, SF6 has a lifetime of 2 to 4 weeks, while C3F8 remains present over 
the course of 1 to 3 months. Critical to the selection of these long-acting gasses in 
intraocular tamponade is managing steadfast patient compliance to a recommended 1 to 2 
week regimen of facedown positioning (2, 3, 8). While the use of these gasses has been 
very successful in achieving postoperative hole closure in patients who practice strict 
adherence to the head positioning guidelines, usually inevitable cataract formation results 
in a generally slower visual recovery period (2). In patients who are unable or unwilling 
to comply with the facedown positioning practices of gas tamponade, silicone oil has 
emerged as an alternative consideration. Although the silicone tamponade force is less 
than that of intraocular gas, patients can typically return to near normal day-to-day 
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activities much sooner than those receiving SF6 or C3F8. However, a disadvantage in 
silicone oil tamponade is the need for a second oil-removal procedure when the initial 
postoperative period completes, and thus, a greater total expense of treatment. 
Independent of time considerations in recovery, some investigators have found better 
overall anatomic and visual outcomes with gas tamponade as compared to silicone oil, 
and yet other case series have observed a higher rate of spontaneous macular hole 
reopening (8).  
Internal Limiting Membrane Removal 
 Another factor that has presented potentially valuable clinical utility is the 
introduction of ILM peeling during conventional vitreous surgery for macular hole. The 
ILM is thought to act as a physiological scaffold for both cellular proliferation and 
contractile tissue element attachment — both factors capable of producing significant 
vitreomacular traction (8). Thus, the theory behind this surgical modification is that 
increasing the flexibility of the retina around a macular hole by ILM removal could 
potentially allow for easier anatomic hole closure (8). ILM removal can be achieved by 
the use of special instruments, and requires surgeons to perform a precise technique of 
peeling over a transparent, unicellular, non-elastic basement membrane (10). The 
difficulty in successful execution of this procedure is two-fold: both poor visibility of 
ILM to the naked eye, as well as the risk of damage to the retina in cases of inappropriate 
removal, render this surgical technique as one requiring extreme vigilance by physicians 
in their practice and perfection of its method.  The most promising development aiding 
clinicians’ ability to successfully carry out this peeling technique arrived at the 
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introduction of an indocyanine green dye (ICG), shown to successfully stain collagen 
fibrils, proteoglycans, Muller cell plasma membranes, and basement membrane of the 
ILM to optimize visualization during macular hole surgery (10). Since the advent of ICG 
staining in ILM removal, trypan blue, brilliant blue, and other dyes have also emerged as 
possible choices for ILM staining in macular hole surgeries. While several studies have 
put forth evidence to support significant enhancement of anatomical closure rates in 
procedures utilizing the technique as compared to primary surgeries without peeling (2), 
technique optimization will likely require further testing by large randomized trials 
comparing outcomes across the various ILM peeling conditions.  
Figure 9: Intraoperative internal limiting membrane removal. View of an eye 
with idiopathic macular hole during internal limiting membrane removal.  
Beginning of continuous curvilinear peel (L) completion of membrane peel (R). 
Indocyanine green stained flap is clearly visualized. Taken from Kadonosono et 
al., 2000 (10).  
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Adjunctive Additives 
 Surgeons seeking to improve success of macular hole surgeries and bypass the 
need for epiretinal membrane peeling have in the past incorporated the use of different 
tissue adhesives in addition to traditional surgical procedures (2). The idea behind these 
additives is that the chemical stimulation of fibroglial proliferation can aid in achieving 
macular hole closure. Transforming growth factor-β is an adjuvant which has been 
explored across a few different case series to date. In coupling the use of this growth 
factor to pars plana vitrectomy and gas tamponade, there was evidence presented of 
elevated closure rates in some macular hole operation series, but additional randomized 
placebo-controlled trials failing to find any statistical differences in adjuvant-receiving 
patients have rendered techniques incorporating additives in macular hole surgery as 
inconclusive and a continued area of investigation (2). 
Complications of Vitrectomy 
 A large majority of phakic eyes are observed to develop cataracts following 
vitrectomy surgery in macular hole repair. Several study series have found the rate of 
visually significant development to be somewhere around in 80% in the first few years 
after a pars plana vitrectomy (8). Considering these markedly high rates of cataract 
formation, many surgeons advocate a combining of macular hole surgery with a 
phacoemulsification and intraocular lens placement. In essence a prophylactic measure, 
this combining of procedures totally eliminates the need for a second operation that so 
often is necessitated for by cataract development in treatment of macular hole (11).  
Additionally, intraoperative retinal tears and postoperative retinal detachments are 
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possible complications accompanying and vitrectomy including macular hole repair, 
although both present low rates of occurrence. In addition, it should be noted that patients 
who have undergone gas bubble tamponade must completely avoid air travel in the 
postoperative recovery period, as ascension to higher altitudes could result in gas 
expansion, an increase in intraocular pressure, and consequential development of damage 
to the optic nerve (8).  
 Interestingly, recent clinical research work on vitreomacular traction syndrome 
(VMT), which occurs when tugging caused by strong retinal adherence of the posterior 
vitreous results in morphological changes to the macula, has explored the potential 
efficacy of intravitreal expansile C3F8 injection treatments alone, a technique known as 
pneumatic vitreolysis, in patients that presented VMT with or without concurrent macular 
holes (11).  The results of the study notably found pneumatic vitreolysis to achieve higher 
rates of VMT resolution and hole closure as compared to other treatment standards in a 
retrospective case series and meta analysis, providing a potentially valuable clinical 
foundation for approaching certain VMT-associated early-stage macular hole 
presentations with a lower rate of complication in treatment (11). 
Treatment of Recurrent Macular Holes 
 While major improvements since the Kelly and Wendel introduction of surgery in 
treatment of macular hole have made intervention largely effective, there exists the 
reality that not all patients undergo these procedures successfully. Studies across the last 
five years of literature concerning surgical outcomes for macular hole treatment report 
closure rates in primary operations to be in the range of 90% (8). While the median of 
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postoperative visual acuity for macular holes successfully sealed in a first surgery is 
approximately 20/40, studies find less favorable acuity outcomes in holes failing to seal 
after primary surgery (8).   
Anatomic closure can be defined clinically as a flattening and reattachment at the 
hole’s rim that extends along the entire circumference of the macular hole (13). By OCT 
imaging analysis, the nature of sealed macular holes can further be classified with regards 
to postoperative continuity of foveal tissue above the retinal pigment epithelial layer, and 
the presence or absence of any defects or interruptions of the neurosensory retina (13).  
Several factors have been retrospectively hypothesized as potential causes at the 
root of postoperative failure in macular hole surgery. From a strictly physical, dexterity-
based perspective, the actual precision of technique during PPV procedures to ensure 
complete peeling of the cortical vitreous is paramount.  Anatomically, surgical failure or 
re-opening of idiopathic macular holes could be related to insufficient stability of the 
glial plug at the hole’s center. While there have been some investigations into the 
possible effect of patient non-compliance with postoperative posture and head-
positioning requirements, it is difficult to gather such subjective data empirically.   
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  Figure 10: Preoperative (A) and postoperative (B) OCT. Representing  
  successful macular hole closure resulting in a normal foveal contour. Kang 
  et al., 2003 (13). 
An important distinction in analysis of macular holes requiring treatment beyond 
primary surgery is the delineation between closed and unclosed groups. In instances 
where PPV and gas exchange treatment yield anatomic closure of macular holes that re-
open some period of time after surgery, the cases are classified as reopened holes. By 
contrast, clinical presentations in which primary surgery fails to establish any 
postoperative anatomic closure are described as unclosed holes. Notably, a single-center 
retrospective cases series that took place over ten years at the United Kingdom’s Royal 
Liverpool Hospital (14) compiled data on 532 patients undergoing pars plana vitrectomy 
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for idiopathic full-thickness macular hole, with successful closure accomplished in 460 
eyes (86%).  The study established outcome rates in the 72 patients who underwent a 
second operation, specifically categorized by unclosed versus reopened cases (14). The 
results of the series illustrated that patients undergoing secondary surgery for macular 
holes had successful overall outcomes in a majority of cases, both among unclosed and 
reopened eyes. The study importantly provided comparative data to support the utility of 
secondary surgery for macular hole in achieving anatomic closure and improvement to 
visual acuity across groups. 
 The predictive value of OCT in retreatment of macular holes is also emerging as a 
highly significant area for further clinical investigation in retreatment of macular holes. A 
2007 publication by Hillenkamp et al. (15) presented evidence concerning hole 
configuration as a strong prognostic indicator of anatomical closure in retreatment of full-
thickness macular holes. In particular, the study characterized holes associated with a cuff 
of subretinal fluid at their margin as having significantly increased likeliness to achieve 
anatomic closure in reoperation following failed primary surgeries. The interventional 
case series documented patients with idiopathic full-thickness macular holes that had 
undergone standard PPV, ICG-assisted ILM peeling, and gas tamponade. In defining a 
mechanism for this finding, the group hypothesized that as macular hole closure depends 
on the centripetal movement of retinal tissue to occupy the foveal region, those cases 
with identifiable cuffs of subretinal fluid achieve a higher rate of facilitated closure as the 
result of an absence of adhesion between the macular hole margin and underlying retinal 
pigment epithelium. (15).  
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Aims and Objectives 
 The goal of the current investigation was to retrospectively analyze outcomes of 
macular hole reoperations among a series of patients in a single treatment center. The 
case series comprised of patients who underwent both primary and secondary pars plana 
vitrectomy procedures for full-thickness macular holes, which either reopened after 
initially-successful primary repairs or remained unclosed postoperatively and thus 
required revision surgery. The objective in gathering this data was firstly to provide 
potentially useful clinical insights as to success rates for recurrent macular hole surgeries 
as performed by a single vitreoretinal surgeon over the course of a decade of macular 
hole repairs. Moreover, the current study aimed to supplement its case series data by 
placing the primary outcome measure of successful anatomic macular hole closure 
following secondary surgery in both the historical context of macular hole surgery, and 
the current medical research niche of macular hole reoperation. The latter was achieved 
by conducting a meta analysis of relevant clinical publications with inclusion criteria 
centering around surgical technique in macular hole operations, and determining 
cumulative statistical calculations with literature deemed to fall within the study’s 
parameters.   
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METHODS  
 
 For the purposes of performing a retrospective clinical case study, a total of 13 
eyes (12 total patients) were selected from archived medical records at the Beth Israel 
Deaconess Medical Center in Boston, Massachusetts. These cases represented those 
which underwent two separate surgical treatments following a diagnosis of full thickness 
macular hole between 2004 and 2013.  The surgeries performed were standard 3-point 
pars plana vitrectomy procedures, with or without internal limiting membrane peeling, 
with or without epiretinal membrane peeling, and tamponade with C3F8, SF6, or silicone 
oil. Following primary surgeries, holes were classified in follow-up as either 
anatomically closed or unclosed (persistent). In the 13 cases currently presented, 
secondary operations were carried out following reopening or persistence of macular hole 
under the same standard surgical conditions, with revision vitrectomies again 
supplemented by optional ILM peeling, ERM peeling, and C3F8, SF6, gas or silicone oil 
tamponade.  
Diagnosis and Background  
 Before beginning any course of surgical intervention, patients were given 
preliminary background on macular holes following an ophthalmoscopic and OCT-
informed diagnosis by an eye center retina specialist. Patients were provided with 
information on the idiopathic nature of macular holes, their increased occurrence rate 
among women,  and a typical age range for onset (between 50 and 70 years). The 
physician then engaged in a broad discussion of treatment options with their patients, 
weighing the benefits of continued observation versus pars plana vitrectomy, membrane 
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peeling, and intraocular gas or silicone oil tamponade. The patients were informed as to a 
generally accepted 90% closure rate for full-thickness macular holes after one surgery.  
 In cases for which patients decided to proceed with surgical intervention, the 
physician then proceeded on to present options for tamponade. The first choice of 
intraocular tamponade, long-acting gas bubbles (SF6 or C3F8), were discussed in the 
context of their mechanism and accompanying head-position regiments. Patients were 
given instruction as to a strict regiment that required 2-week commitment after surgery, 
and which called for maintenance of face down positioning during 45 minutes of every 
hour, while awake, on their sides at night. The instructed facedown regiment was since 
shortened to 1 week once routine ILM peeling was introduced into macular hole repair 
operations. In patients who were unable or unwilling to adhere to these requirements (or 
who had to travel by air within 1-3 months after surgery), silicone oil was chosen for 
tamponade, with understanding that a brief, 15 minute removal surgery would have to 
take place anywhere between 8 to 12 weeks after the primary operation.  
 Lastly, patients were given a detailed account of risks associated with vitrectomy 
for macular hole repair. The physician informed patients that 10% of cases do not close 
with surgery or reopen after successful macular hole closure, and that in these instances 
additional surgery to close the macular hole is typically performed. Patients were told 
there exists a 1 in 1,000 risk of bleeding and infection, as with any intraocular 
procedures, that can lead to rare complications resulting in total loss of vision.  Moreover, 
the physician discussed a 1 in 100 risk for development of retinal tears or retinal 
detachments, which can typically be corrected at the time of surgery, but in rare cases can 
	  	  
26 
require an additional surgical repair. In patients who were still phakic at the time of 
surgery, the physician recommended the combining of cataract extraction and intraocular 
lens placement with vitrectomy, due to the elevated rates of visually significant cataract 
formation postoperatively in macular hole treatment.  
 After the indications, risks, benefits, and alternatives were thoroughly presented 
and deliberated upon, patients signed consent forms and were scheduled for operation as 
soon as was possible. Additionally, patients were instructed to remain in a fasting state 
after midnight the day before surgery, and to take any necessary medications with just a 
sip of water in the morning. 
Surgical Procedure 
 Inside the operating room, EKG, O2, and blood pressure monitors were put in 
place and monitored throughout the case. The operative eye was then prepared and 
draped by typical ophthalmic protocol, and a wire lid speculum was placed to keep the 
lids apart. Next, a retrobular infusion of a 50:50 mixture of 2% lidocaine and 0.75% 
marcaine with epinephrine was given behind the operative eye to produce suitable 
asnethesia and akinesia.  Sclerotomies were then carefully made 3.5 mm posterior to the 
limbus in the superonasal, superotemporal, and inferotemporal quadrants. A 4 mm 
infusion cannula was inserted into the inferotemporal sclerotomy. The tip of the infusion 
cannula was inspected to ensure that it was in the vitreous cavity prior to turning on the 
infusion. Triamcinolone acetonide (Kenalog) was then used to stain the vitreous gel for 
visualization. In the case that posterior hyaloid remained attached, the retinal surgeon 
elevated the hyaloid using the soft-tip aspirating cannula and vitreous cutter in order to 
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create a posterior vitreous detachment. Once this was done, peripheral vitrectomy could 
be performed 360 degrees around. Internal limiting membrane staining was accomplished 
by use of ICG dye in the large majority of cases. ICG dye was applied twice for a total of 
2 minutes, and followed by ILM forcep peeling of the internal limiting membrane 360 
degrees around the macular hole. In the instance of epiretinal membrane association with 
the ILM, dissection was adjusted and carried out accordingly. In the case of impact 
hemorrhage associated with any portion of the vitrectomy, notes were made as to the 
details and measures were taken to stabilize conditions during and after surgery.   
 Surgeons then performed a complete 360-degree scleral depressed examination to 
ensure no evidence of retinal tear or detachment. At this stage, patients underwent 
tamponade by either complete fluid-air exchange or silicone oil tamponade.  Infusions of 
50 cc of 20% or 25% SF6 or C3F8 gas were performed and pressures were ensured to be 
normal. In the case of silicone oil tamponade, patients received either 1,000 or 5,000 
centistokes. After sclerotomies were closed and found to be-water tight, a subconjuctival 
injection of Kefzol and dexamethasone was given. Operative eyes were patched with 1 
drop of 0.25% scopolamine, Bacitracin ointment, and a soft eye pad with hard eye shield. 
Due to the delicate intraocular manipulations involved the procedure, fully-trained 
ophthalmologists were required in all operations to assist with surgery. Patients had 
patches removed on postoperative day one, and given instruction for proper use of topical 
drops.  
 For all secondary operations, the standard preoperative discussions and 
indications were again presented to patients.  In these cases of recurrent full thickness 
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macular holes, whether reopened or unclosed, the physician informed patients that the 
loss of central vision and corresponding visual symptoms would likely remain at the 
current level if untreated with reoperation, and some degree of peripheral vision could be 
salvaged in those instances. Revision vitrectomies were performed under the same 
monitored anesthesia controls as used previously.  
Outcome Measures 
 The main outcome measure of this study was anatomical closure of macular hole 
as observed by ophthalmoscopic examination and supplementary OCT image analysis by 
the vitreoretinal specialist in clinic. When available, visual acuity measures both pre- and 
postoperatively were gathered for patients across primary and secondary surgeries. Time 
duration between macular hole diagnosis and primary operation was informed by medical 
record assessment notes made during eye center visits.  Surgeon operative notes were 
consulted for details as to the specific conditions surrounding each individual procedure.  
  
  
 
 
 
 
	  	  
29 
RESULTS 	   The following results reflect the collected data from a case series of 13 recurrent 
macular hole patients, organized by the respective outcomes of primary and secondary 
surgery, as well as background information on gender, age, and stage classification. 
Table 1: Macular Hole Diagnoses & Primary Surgery Outcomes   
Case # Age Sex Diagnosis to 
Surgery 
Duration 
Macular 
Hole 
Stage 
Tamponade ILM  
Peel? 
Macular Hole 
Status Postop 
#1 
1 67 F 1 month 2 C3F8 gas No Closed 
2 71 F 1 month 3 SF6 gas  Yes Closed 
3 69 F 1 month 2 C3F8 gas No Closed 
4 59 F 2 weeks 2 C3F8 gas Yes Closed 
5 68 F 1 month 2 Silicone oil Yes Closed 
6 82 F 5 months 2 SF6 gas  Yes Unclosed 
7 55 M 1 month 3 Silicone oil Yes Closed 
8 60 F 2 weeks 3 Silicone oil Yes Closed 
9 62 F 1 month 3 Silicone oil No Closed 
10 63 F 1 month 3 Silicone oil Yes Closed 
11 61 F 1 month 3 C3F8 gas No Closed 
12 78 M 2 month 3 C3F8 gas No Unclosed 
13 71 F 1 month 3 SF6 gas  Yes Closed 
 
 The series sample consisted of 10 female and 2 male patients, as Cases 9 and 10 
represent two separate macular hole recurrences in either eye of a single subject, one year 
apart respectively. The average age of cases at the time of primary operation was 67 
years. Of the 13 total macular hole cases presented, 5 were classified as stage 2 full-
thickness macular holes, and 8 were classified as stage 3 full-thickness macular holes. 
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The average duration of time between clinical diagnosis of macular hole by retina 
specialist and primary operation was 1.3 months, although it should be noted that Case 6 
describes an outlier data point of 5 month’s delay before surgical intervention. Of the 
primary macular hole repair operations, 11 of 13 resulted in initial macular hole closure 
(84.6%), while 2 of 13 persisted as unclosed macular holes (15.5%). 8 of 13 cases 
underwent ILM peeling during primary surgery. Cases 4, 7, and 13 underwent epiretinal  
membrane dissection during primary operation and all achieved primary hole closure. 
Table 2: Secondary Surgery Outcomes 
 
Case # Age Sex Recurrent 
Macular 
Hole Type 
Reoperation 
Tamponade 
Reoperation 
ILM  
Peel? 
Macular Hole Status 
Postop #2 
1 67 F Reopened Silicone oil Yes Closed 
2 71 F Reopened C3F8 gas Yes Closed 
3 69 F Reopened Silicone oil Yes Closed 
4 59 F Reopened SF6 gas  No Closed 
5 68 F Reopened SF6 gas  Yes Closed 
6 82 F Unclosed  Silicone oil Yes Unclosed 
7 55 M Reopened Silicone oil Yes Unclosed 
8 60 F Reopened Silicone oil Yes Closed 
9 62 F Reopened Silicone oil No Closed 
10 63 F Reopened Silicone oil Yes Unclosed 
11 61 F Reopened Silicone oil Yes Closed 
12 78 M Unclosed  Silicone oil Yes Closed 
13 71 F Reopened Silicone oil Yes Closed 
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 Of the 13 total macular hole reoperations, 10 resulted in anatomical closure 
(76.9%). Nine of 11 reopened macular holes achieved anatomical closure (81.8%) and 1 
of the 2 unclosed holes were successfully closed after secondary surgery (50%). 11 of 13 
total reoperations underwent ILM peeling, and in instances where ILM peeling was 
performed in primary operation, the peeling area was increased during secondary repair. 
Cases 1, 9, and 12 underwent epiretinal membrane dissection during reoperation, with all 
achieving successful hole closure.  
Table 3: Postoperative Outcomes & Visual Acuity 
Case # Recurrent 
Macular Hole 
Type 
Macular Hole 
Status Postop #2 
Visual Acuity Pre-
Primary Operation 
BCVA Post-
Reoperation  
1 Reopened Closed 20/200 20/200 
2 Reopened Closed CF  20/80 
3 Reopened Closed 20/60 20/30 
4 Reopened Closed 20/50 20/25 
5 Reopened Closed 20/200 20/40 
6 Unclosed Unclosed CF  CF 
7 Reopened Unclosed 20/80 20/200 
8 Reopened Closed - - 
9 Reopened Closed - - 
10 Reopened Unclosed - - 
11 Reopened Closed 20/60 20/200 
12 Unclosed Closed CF 20/200 
13 Reopened Closed 20/200 20/40 
  
Table 3 presents all 13 cases of reoperation classified by recurrent macular hole 
type (Reopened vs. Unclosed) and corresponding visual acuity data where available (at 
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time of primary operation vs. best recorded visual acuity after secondary operation). 8 of 
the 10 cases for which visual acuity data was available presented post-secondary 
operation visions at either the same level as or improved from acuity measured at the 
time of primary surgery (80%). Measures reported as “CF” refer to a “Count Fingers” 
visual acuity. In instances where vision is worse than 20/400, patients are asked to count 
the number of fingers on a hand at distances typically between 3 and 6 feet away during 
examination.  
 In order to better understand the results of the current study within the landscape 
of clinical research on macular hole reoperation, a meta analysis was performed using 10 
different publications found to meet a predefined set of parameters. The inclusion criteria 
for these papers required that patients presented full-thickness macular holes deemed to 
have failed primary surgical repair— either due to a failure to close the macular hole or 
the reopening of a previously closed macular hole. In addition, primary and secondary 
surgeries were required to consist of 3-port pars plana vitrectomies, with or without ILM 
peeling, with or without ERM peeling and tamponade of C3F8, SF6, or silicone oil. 
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Table 4: Meta Analysis of Macular Hole Reoperations (14-23) 
 
The cumulative results of this meta analysis found the successful secondary 
surgery rate among all 10 case series to be 79% (218 of 276 total reoperations). The 
success rate of secondary operations for macular holes unclosed after primary operation 
was 75% (122 of 162 “unclosed” reoperations). The success rate of secondary operations 
for macular holes which reopened after initially achieving a postoperative anatomical 
closure was found to be 91% (42 of 46 total “reopened” reoperations).  It should be noted 
that a much larger sample size underwent reoperation with macular holes unclosed after 
primary surgery as compared to the “reopened” group (162 vs. 46 total cases).   
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DISCUSSION 
 The data presented in the current retrospective case series falls in line with much 
of the current scientific literature on recurrent macular hole surgery. Although the success 
rate of primary macular hole operation across all surgeries is widely accepted as quite 
high (90%) (8), recurrence of holes by reopening or persistence still remains a 
complication in clinical intervention and management of this ocular condition worthy of 
investigation. The combined success rate of reoperation, between both reopened and 
unclosed recurrent macular hole groups, was found to be 76.9% in the current series as 
compared to 79% in meta analysis. While a majority of surgeries for recurrent macular 
holes in the meta analysis were found to be performed in unclosed cases, only two such 
cases were represented in the current series, with successful closure achieved in one of 
the reoperations (50%). In the single case (#6) representing a recurrent macular unclosed 
after both primary and secondary surgeries, a significantly lengthy duration of 5 months 
passed between the time of in-clinic macular hole diagnosis and date of primary 
operation. This delay in initial operation could undoubtedly have played a role in the 
inability to achieve surgical macular hole closure in either repair procedure. As a whole, 
the combined outcome measure results of the current series provide evidence to confirm 
the benefit of secondary surgery in treatment of recurrent macular hole. While more cases 
of unclosed persistent holes will need to be compiled before any cross-group conclusions 
can be drawn, a high percentage of reoperations achieved successful macular hole 
closure, the majority of which were accompanied by the maintenance of pre-surgery 
visual acuity levels, or improvements from baseline.  
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 In compiling the selected publications for meta analysis, each presents valuable 
information relating to various surgical considerations important to the treatment of 
macular holes. Notably, the previously discussed Liverpool Hospital case series by 
Valldeperas and Wong (14) found patients with full thickness macular holes unclosed 
after primary surgery to have lower reoperation closure rates, and poorer overall 
postoperative visual acuity outcomes, as compared to reopened holes. While the 
Valldeperas series achieved closure of macular holes in 100% (21 of 21) of reopened 
cases, it should be noted that the use of autologous platelet concentrate as adjuvant in 
surgery without a corresponding control group makes it difficult to extrapolate a 
definitive conclusion behind the observed results. Moreover, the case series presented a 
total of 72 patients that underwent secondary surgery for macular hole repair, of which a 
large majority consisted of unclosed macular holes as compared to reopened cases (51 of 
72, 70% of total reoperations). Coupled with the fact that several surgeons performed 
repair operations over the given study period, this elevated rate of anatomically unclosed 
macular holes following primary surgery should be paid heed to and considered before 
drawing any conclusions across the two experimental groups.   
 By general consensus, rates for secondary surgeries in reopened holes were 
indeed found to be higher than those for unclosed cases in cumulative meta analysis of 
published literature (91% closure of reopened holes vs. 75% closure of unclosed hopes), 
though there exists disparity in the number of represented cases per group. However, 
there is undoubtedly a need within the medical community to produce larger-scale case 
	  	  
36 
series data comparing surgical outcomes between the two types of recurrent macular hole 
groups before success rates can be considered definitive.  
 In Ezra et al.’s 1997 series (19), eyes that had previously undergone macular hole 
surgery and remained unclosed were retreated with secondary surgery and C3F8 gas 
tamponade. Anatomical closure was achieved in 80% of the previously unclosed cases, 
over half of which underwent rigorous epiretinal membrane dissection (membranectomy) 
as part of reoperation. By comparison, one case in the current series (#12) presented an 
unclosed macular hole that underwent secondary surgery with dissection of a notably 
thick epiretinal membrane, and did successfully achieve anatomical closure.  
 D’Souza et al. (18) presented the largest case series on macular hole reoperation 
within a patient population whose ILM was routinely peeled in primary surgical 
procedures (18). While an 88% success rate was observed in primary operation, 
reoperation rendered decreased anatomical closure rates of 46.7% among a large majority 
of macular holes unclosed after primary surgery. The paper hypothesized that reoperation 
is less likely to succeed once ILMs have been peeled, and found that secondary surgeries 
with enlargement of ILM peeling areas, in both reopened (4 total) and unclosed groups 
(21 total), were not associated with significantly better outcome measures. In the 11 
secondary operations of the current series for which ILM peeling was performed, 7 cases 
underwent ILM peel in primary operation and had the peeling area enlarged in 
reoperation, and 4 cases underwent ILM peel for the first time. Successful closure was 
achieved in 8 of 11 cases (72.5%). Worth noting in the De Souza et al.’s study design was 
that retrospective data collection was carried out using medical records belonging to three 
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different surgeons. In analyzing an operation which critically relies on the most delicate 
of intraocular manipulations, variables associated with a particular’s surgeon’s technique 
and dexterity can have a potentially confounding effect in regards to the variable of ILM 
peeling when unaccounted for across a sample. Hejsek et al (16) presented a series of 6 
cases in which primary PPV procedures were supplemented by ILM peeling in an area of 
2-3 disc diameters. All cases were unclosed after first surgery, and underwent a second 
operation with enlargement of ILM peeling area, and a special surgical technique to 
loosen the edges of macular holes manually by silicone brush. In the limited sample size 
of cases presented, 100% anatomical closure was observed following reoperation. This 
unusually high closure rate was attributed by the authors to be a result of the manual 
loosening of the elevated rigid macular hole edges, and the potential utility of this 
surgical technique could undoubtedly be explored in greater detail across larger sample 
sizes.  
 A limitation of current investigatory studies on macular hole retreatment is the 
retrospective nature of medical records, spanning across time periods with varying 
degrees of technological availability to vitreoretinal specialists in clinic. Factors such as 
macular hole diameter and the presence or absence of subretinal fluid cuffs at the base of 
macular holes are now readily measurable through OCT analysis, and could certainly 
prove valuable as electronic databases grow in hospitals across all institutions. In order to 
make definitive progress in improving success rate for patients with recurrent macular 
holes, there is a need for greater collaborative efforts between the medical community at 
large. As in all realms of medical intervention and management, there exists a degree of 
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useful debate and discussion between clinicians over current treatment modalities and 
any potential improvements to technique. In the specific context of recurrent macular 
hole surgery, questions regarding surgical considerations such as ILM peeling and 
postoperative head-positioning requirements following intraocular gas tamponade are 
areas that could benefit from collaboration to produce standardized practice patterns. 
More generally, future research in the area of macular holes should undoubtedly continue 
the multiple decades-long effort to find some type of root behind this otherwise 
“idiopathic” development of disease. Perhaps attempts to explore potential associative 
causes of macular hole could venture into previously uncharted waters, bridging 
laboratory sciences and clinical research to produce novel, unique, and outside-the-box 
investigatory study designs. In the process of drafting the current cases series, one such 
idea emerged as a possible next step in continuing research on macular holes. 
Considering an idiopathic macular hole occurrence rate among women found to be as 
high as a 72% majority in one case-control study, with over 50% of cases occurring in 
individuals 65 years of age and older, there could be otherwise unexplored factors such as 
physiological gender-specific aging patterns among women as compared to men. Could 
the presence of estrogen and progesterone receptors in the retina predispose 
postmenopausal women to macular hole development? Could the gradual decreases in 
hormone levels result in atrophy of cells and breakdown of adhesion at the fovea? Could 
the application of hormonal treatment in early macular holes result in cellular 
regeneration and prevention of vitreofoveal separation? There is much room for future 
work within the landscape of ophthalmologic research, and the current case series seeks 
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to offer outcome data from a single-center, single-surgeon set of recurrent macular hole 
operations to be put in context both historically, with background origins of disease 
diagnosis and treatment, and comparatively, by meta analysis across the relevant 
publications of the present day clinical research realm.  
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Public Health Brigades (Secretary 2012, Vice President 2013), Iranian American 
Medical Association (IAMA), University Dean’s List (2010, 2011, 2012)  
§ Westwood High School: September 2005 – June 2009  
Activities and Societies: National Honors Society, Class Officer (Vice President), 
WHS Student Council (President), WHS Student Representative to MA Board of 
Education, Varsity Tennis (Captain), Mock Trials (Officer), National Latin Exam 
Gold Medalist (2006, 2007, 2008), Excellence in Latin Studies (2009)  
Experience 
§ Massachusetts General Hospital Vaccine and Immunotherapy Center: 2014 – Current  
Graduate researcher role as a member of the Poznansky Laboratory research team, 
with project work assessing the novel isoform-specific roles of CXCL12 
chemokine in tumor metastasis and growth in both ovarian cancer and 
mesothelioma models.  
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§ Beth Israel and Deaconess Medical Center: 2014 – Current  
Clinical researcher working on projects exploring the various surgical outcomes 
and considerations in recurrent macular hole repair operations. Duties also include 
working independently during full clinical hours performing visual acuity and eye 
exam work-ups on patients, optical coherence tomography scans, dilating and 
anesthetizing patient’s eyes before examinations, and assisting surgeons during 
intravitreal injections. Additional experience in performing patient examinations 
using indirect ophthalmoscopy and laser photocoagulation procedure observation.  
§ Lapuck Laboratories Inc. Pharmaceutical Testing:  2012 – 2014  
Began work on a research project studying antimicrobial effects of an Aqueous O-
Zone solution in surface sanitation and overall antibiotic efficacy. General 
experiences included plate-preparation, bacterial swabs, incubation, treatment- 
measures, data analysis, and adherence to sanitary laboratory practices.   
§ Global Brigades of Boston University:  September 2010 – May 2013 
Served as Vice President of university’s public health service organization 
chapter, organizing student-led missions abroad to implement sustainable holistic 
health projects in  underdeveloped countries, alongside Medical and Dental 
brigades. Partook in two such missions as an undergraduate chapter leader: 
- El Cantón, Honduras – January 2012 – 7-day mission, focus on oral 
health & sanitation in a mountainous community of sustenance coffee 
farmers in rural Honduras. Provided free community-wide public health 
clinics, working in collaboration with Honduran government & military  
- Embera Puru Tribe, Panama – January 2013 - First ever student-led 
Public Health Brigade to Panama. Worked with an indigenous tribe of 
along the Colombian border Volunteer work and health-practice education 
clinics aimed at stopping preventable illness among region’s inhabitants & 
were supplemented by the distribution of free healthcare materials  U.S. 
§ Fulbright Summer Institute Student Ambassador: May – August 2010   
Worked as the lead student ambassador for a summer-long European-exchange 
program, operating on a grant from the Fulbright Scholar commission, responsible 
for organizing an intensive summer term of classes and community service. 
 Experience included presenting at U.S. State Department in Washington, D.C. on 
the benefits of student-led foreign exchange for the international community. 
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§ Iranian American Medical Association (IAMA) 2011 – Current  
Organization of physicians and health science students hosting monthly 
symposiums on topics in relevant fields. Members participate in lectures, 
discussions, debates, and mentoring.   
§ Caritas Norwood Hospital Volunteer 2007 - 2009   
Volunteer work at a local hospital, working with patients pre- and post-surgery in 
preparation, recoveries, and discharge. Direct patient interaction, including 
monitoring and transport. Worked alongside the hospital’s Day Surgery and 
Recovery team.  
Skills 
§ Laboratory research protocols  
Diverse experience in a wide range of experiments: PCR amplification, DNA 
ligation, bacterial transformations, tissue culture harvest, lentiviral transfection, 
Western Blot assays, data collection, laboratory reports, and literature reviews  
§ Multimedia editing, web page design, statistical analysis 
Currently serving as operating Web Administrator for AdvancingCures.org. 
Experiences include site design on WordPress platform, and managing a blog. 
Operational skills in Microsoft Excel, PowerPoint, IBM SPSS, FinalCut Pro.  
§ Linguistics  
Native fluency in English and Persian. High-level of conversant fluency in 
Spanish, regularly used clinically for direct patient care without interpreters. 
 
